Earnings History Data for Maravai LifeSciences Holdings, Inc. (MRVI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	AH		MRVI	Maravai LifeSciences Holdings, Inc.	1,980	-0.09	-0.04	-0.02	Maravai LifeSciences Holdings Non-GAAP EPS of -$0.02 misses by $0.01, revenue of $65.2M misses by $2.53M [11/7/2024 4:21 PM]	5.04	-2.80 (-35.78%)	4.75	-3.09 (-39.41%)	4.52 - 11.56	10,132,548	1,510,000	579,744
Maravai LifeSciences Holdings Non-GAAP EPS of -$0.02 misses by $0.01, revenue of $65.2M misses by $2.53M [11/7/2024 4:21 PM] Maravai LifeSciences stock plunges 39% amid lowered revenue forecast [11/8/2024 12:57 PM] Maravai LifeSciences Reports Third Quarter 2024 Financial Results [2024-11-07 04:01PM] Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research [2024-11-07 04:01PM]
07-08-2024	AH		MRVI	Maravai LifeSciences Holdings, Inc.	2,360	-0.08	-0.03	-0.06	Maravai LifeSciences Holdings GAAP EPS of -$0.05 misses by $0.01, revenue of $73.4M beats by $1.77M [8/7/2024 5:26 PM]	8.54	-0.56 (-6.15%)	9.10	0.0 (0.00%)	4.52 - 11.70	5,607,126	1,470,000	18,538
Maravai LifeSciences Holdings GAAP EPS of -$0.05 misses by $0.01, revenue of $73.4M beats by $1.77M [8/7/2024 5:26 PM]
08-05-2024	AH		MRVI	Maravai LifeSciences Holdings, Inc.	2,270	-0.11	-0.06	0.03	Maravai LifeSciences Holdings GAAP EPS of -$0.09 misses by $0.04, revenue of $64.2M beats by $3.65M [5/8/2024 4:13 PM]	9.92	1.05 (11.84%)	8.87	0.0 (0.00%)	4.52 - 16.62	4,801,297	1,710,000	51,630
Maravai LifeSciences Holdings GAAP EPS of -$0.09 misses by $0.04, revenue of $64.2M beats by $3.65M [5/8/2024 4:13 PM]
22-02-2024	AH		MRVI	Maravai LifeSciences Holdings, Inc.	1,330	-0.05	-0.04	0.35	Maravai LifeSciences Holdings GAAP EPS of -$0.80 misses by $0.78, revenue of $74.14M beats by $9.8M [2/22/2024 4:41 PM]	8.36	3.25 (63.50%)	7.12	2.01 (39.33%)	4.52 - 16.90	24,722,178	2,690,000	372,297
Maravai LifeSciences Holdings GAAP EPS of -$0.80 misses by $0.78, revenue of $74.14M beats by $9.8M [2/22/2024 4:41 PM] Maravai 2024 revenue guidance propels stock 20% higher [2/22/2024 5:16 PM]
07-11-2023	AH		MRVI	Maravai LifeSciences Holdings, Inc.	1,730	-0.02	-0.03	0.37	Maravai LifeSciences Holdings GAAP EPS of -$0.05 misses by $0.04, revenue of $66.9M misses by $8.62M [11/7/2023 4:28 PM]	4.71	-2.17 (-31.47%)	6.14	-0.74 (-10.76%)	4.60 - 16.90	11,335,765	2,120,000	8,496
Maravai LifeSciences Holdings GAAP EPS of -$0.05 misses by $0.04, revenue of $66.9M misses by $8.62M [11/7/2023 4:28 PM] Maravai hits 52-week low after Q3 miss, cost cutting [11/8/2023 1:50 PM]
07-08-2023	AH		MRVI	Maravai LifeSciences Holdings, Inc.	3,030	-0.06	-0.02	0.54	Maravai LifeSciences Holdings Non-GAAP EPS of $0.00 misses by $0.01, revenue of $68.9M misses by $2.23M [8/7/2023 5:23 PM]	11.09	0.07 (0.59%)	9.44	-1.58 (-14.34%)	9.20 - 27.82	7,852,395	3,190,000	203,177
Maravai LifeSciences Holdings Non-GAAP EPS of $0.00 misses by $0.01, revenue of $68.9M misses by $2.23M [8/7/2023 5:23 PM] Maravai down 11% on Q2 misses, 2023 guidance cuts [8/7/2023 5:54 PM] Maravai LifeSciences falls as Q2 miss prompts KeyBanc downgrade [8/8/2023 9:16 AM]
08-05-2023	AH	4:05 PM ET (May 8)	MRVI	Maravai LifeSciences Holdings, Inc.	1,760	0.03	0.04	0.54	Maravai LifeSciences Holdings Non-GAAP EPS of $0.03 misses by $0.01, revenue of $79M misses by $0.72M [5/8/2023 4:17 PM]	12.08	-1.82 (-13.09%)	12.29	-1.61 (-11.58%)	11.89 - 35.82	9,546,258	2,680,000	163,064
Maravai LifeSciences Holdings Non-GAAP EPS of $0.03 misses by $0.01, revenue of $79M misses by $0.72M [5/8/2023 4:17 PM] Maravai cut to neutral at Goldman Sachs following lowered 2023 guidance [5/9/2023 3:01 PM]
22-02-2023	AH	4:05 PM ET (Feb 22)	MRVI	Maravai LifeSciences Holdings, Inc.	1,970	0.35	0.34	0.45	Maravai LifeSciences Holdings Non-GAAP EPS of $0.35 beats by $0.01, revenue of $204.7M misses by $0.25M [2/22/2023 4:42 PM]	14.97	1.14 (8.28%)	13.87	0.04 (0.29%)	12.16 - 41.82	3,036,021	1,060,000	24,183
Maravai LifeSciences Holdings Non-GAAP EPS of $0.35 beats by $0.01, revenue of $204.7M misses by $0.25M [2/22/2023 4:42 PM]
02-11-2022	AH	4:00 PM ET (Nov 2)	MRVI	Maravai LifeSciences Holdings, Inc.	2,180	0.37	0.32	0.44	Maravai LifeSciences Holdings Non-GAAP EPS of $0.37 beats by $0.04, revenue of $191.3M misses by $4.32M [11/2/2022 4:32 PM]	14.49	-0.86 (-5.63%)	13.34	-2.02 (-13.15%)	13.49 - 46.43	3,896,076	1,620,000	35,180
Maravai LifeSciences Holdings Non-GAAP EPS of $0.37 beats by $0.04, revenue of $191.3M misses by $4.32M [11/2/2022 4:32 PM] Maravai slumps 13% on slashed FY22 revenue outlook, Q3 earnings fall [11/3/2022 9:15 AM] Maravai hits new 52-week low as Bank of America downgrades on 2023 outlook [11/3/2022 2:09 PM] Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript [Nov-03-22 12:30AM] Maravai LifeSciences Holdings, Inc. (MRVI) Q3 Earnings Beat Estimates [Nov-02-22 06:15PM] Maravai LifeSciences Reports Third Quarter 2022 Financial Results [Nov-02-22 04:05PM]
04-08-2022	AH	4:05 PM ET (Aug 4)	MRVI	Maravai LifeSciences Holdings, Inc.	3,420	0.54	0.45	0.44	Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M [8/4/2022 4:43 PM]	26.88	0.60 (2.28%)	26.88	0.0 (0.00%)	23.05 - 63.55	2,448,173	1,490,000	5,393
Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M [8/4/2022 4:43 PM] Maravai Lifesciences Reports Second Quarter 2022 Financial Results [Aug-04-22 04:03PM] Maravai LifeSciences Holdings, Inc. (MRVI) Q2 Earnings and Revenues Beat Estimates [Aug-04-22 05:55PM] CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results [Aug-04-22 04:51PM]
05-05-2022	AH	4:05 PM ET (May 5)	MRVI	Maravai LifeSciences Holdings, Inc.	4,030	0.54	0.43	0.26	Maravai LifeSciences Holdings Non-GAAP EPS of $0.54 beats by $0.10, revenue of $244.29M beats by $12M [5/5/2022 4:41 PM]	32.37	3.82 (13.38%)	28.55	0.0 (0.00%)	23.16 - 63.55	4,534,699	1,820,000	528
Maravai LifeSciences Holdings Non-GAAP EPS of $0.54 beats by $0.10, revenue of $244.29M beats by $12M [5/5/2022 4:41 PM] Maravai LifeSciences gains after speculation on takeover interest [5/6/2022 12:42 PM] Adial Pharmaceuticals Announces Research Collaboration with UC San Diego to Advance Purnovates Adenosine Compounds as Potential Treatments for Inflammatory Diseases & Disorders [May-04-22 09:15AM] Maravai LifeSciences Reports First Quarter 2022 Financial Results [May-05-22 04:05PM] Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates [May-05-22 06:45PM] Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2022 Earnings Call Transcript [May-06-22 01:30AM]
23-02-2022	AH	4:05 PM ET (Feb 23)	MRVI	Maravai LifeSciences Holdings, Inc.	4,310	0.45	0.38	0.13	Maravai LifeSciences Holdings GAAP EPS of $0.42 beats by $0.08, revenue of $228.44M beats by $20.35M [2/23/2022 4:58 PM]	33.44	-0.40 (-1.17%)	35.35	1.51 (4.46%)	23.16 - 63.55	3,695,149	1,811,211	34,693
Maravai LifeSciences Holdings GAAP EPS of $0.42 beats by $0.08, revenue of $228.44M beats by $20.35M [2/23/2022 4:58 PM] Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance [Feb-23-22 04:05PM] Maravai LifeSciences Holdings, Inc. (MRVI) Q4 Earnings and Revenues Beat Estimates [Feb-23-22 05:35PM] Can Maravai LifeSciences Holdings, Inc. (MRVI) Climb 56% to Reach the Level Wall Street Analysts Expect? [Feb-24-22 10:00AM]
10-11-2021	AH	4:05 PM ET (Nov 10)	MRVI	Maravai LifeSciences Holdings, Inc.	4,600	0.44	0.35	0.00	Maravai LifeSciences Holdings EPS beats by $0.15, beats on revenue [11/10/2021 4:28 PM]	36.49	1.30 (3.68%)	37.50	2.30 (6.53%)	23.62 - 63.55	2,689,535	2,030,000	600
Maravai LifeSciences Holdings EPS beats by $0.15, beats on revenue [11/10/2021 4:28 PM] Maravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022 [Nov-10-21 04:05PM] Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2021 Earnings Call Transcript [Nov-11-21 09:30AM]
10-08-2021	AH	4:05 PM ET (Aug 10)	MRVI	Maravai LifeSciences Holdings, Inc.	13,860	0.44	0.31	0.00	Maravai LifeSciences Holdings EPS beats by $0.12, beats on revenue [8/10/2021 4:26 PM]	50.10	0.06 (0.12%)	55.50	5.46 (10.91%)	23.62 - 56.68	2,031,205	1,050,000	6,320
Maravai LifeSciences Holdings EPS beats by $0.12, beats on revenue [8/10/2021 4:26 PM] Maravai LifeSciences rebounds as 2021 guidance beats expectations [8/10/2021 5:13 PM] Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance [Aug-10-21 04:05PM] Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2021 Earnings Call Transcript [Aug-10-21 10:31PM] Dow Jones Futures: Market Rally Mixed As White House Sees Covid Cases 'Leveling Off'; Tesla Rival Nio Beats Views [Aug-11-21 07:35PM]
10-05-2021	AH	4:05 PM ET (May 10)	MRVI	Maravai LifeSciences Holdings, Inc.	9,170	0.26	0.19	0.00	Maravai LifeSciences Holdings EPS beats by $0.05, beats on revenue [5/10/2021 4:22 PM]	35.29	-0.53 (-1.48%)	35.00	-0.82 (-2.29%)	23.62 - 40.24	1,439,673	1,140,000	665
Maravai LifeSciences Holdings EPS beats by $0.05, beats on revenue [5/10/2021 4:22 PM] Medical Product Stock Q1 Earnings on May 10: MRVI, TGTX & More [May-07-21 09:20AM] Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A to Host Earnings Call [May-10-21 02:45PM] Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance [May-10-21 04:05PM] IPO Stock Maravai Lifesciences Crushes First-Quarter Forecasts [May-10-21 04:18PM] This IPO Stock Is Staring Down A Buy Point; Will Vaccines Drive It There? [May-10-21 05:00PM] Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2021 Earnings Call Transcript [May-11-21 03:30AM]
02-03-2021	AH	After the close (Mar 2)	MRVI	Maravai LifeSciences Holdings, Inc.	8,380	0.13	0.12	0.00	Maravai LifeSciences Holdings EPS beats by $0.04, beats on revenue [3/2/2021 4:15 PM]	36.33	1.27 (3.62%)	39.25	4.19 (11.95%)	23.62 - 40.24	5,007,096	782,770	67,360
Maravai LifeSciences Holdings EPS beats by $0.04, beats on revenue [3/2/2021 4:15 PM] Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Q4 2020 Earnings Call Transcript [Mar-03-21 10:59AM] Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance [Mar-02-21 04:05PM] Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A to Host Earnings Call [Mar-02-21 02:45PM]